Abstract:BackgroundProlyl oligopeptidase (POP) is a serine endopeptidase that is widely distributed in vivo, particularly in the liver. Significant changes in functional mitochondrial proteins involved with mitochondrial oxidoreductases/transporters and nucleic acid binding proteins were observed after POP inhibition in the liver, which suggested a role of POP in regulating liver energy metabolism. Steatosis in nonalcoholic fatty liver disease (NAFLD) is associated with disturbances in lipid and energy metabolism in hepatocytes. Here, we aimed to study the effect of POP on hepatocyte steatosis. MethodsThe human liver cell line L02 was used to investigate the biological effects of POP. An in vitro cell model of steatosis was successfully induced with oleic acid and palmitic acid. L02 cells were also subjected to S17092 (a POP inhibitor) at different concentrations for 24 or 48 h. Ac-SDKP levels and POP activity were measured to assess the rate of inhibition of POP by S17092. The POP gene and protein expression levels were detected using real-time PCR and Western blots, respectively. Oil red O staining was performed and the triglyceride levels in the L02 cells were also measured. Cell proliferation and apoptosis were detected using CCK-8 and flow cytometry, respectively. The expression of genes involved in lipid metabolism was detected using real-time PCR. The effects of POP inhibition on LC3B II were detected by Western blot.ResultsCompared with the control, the POP mRNA levels increased by approximately 30%, and the POP protein levels increased by almost 60% in the steatotic L02 cells. After S17092 (0.026 similar to 130 mu M) incubation for 24 or 48 h, cell proliferation was significantly decreased in the free fatty acid (FFA)-treated cells at 26-130 mu M; however, S17092 did not affect the proliferation of L02 cells after 24 h of incubation with S17092 at 0.026-65 mu M without FFA treatment. S17092 treatment (13 and 26 mu M) also elicited no significant effect on apoptosis in normal L02 cells, but FFA treatment increased cell apoptosis, which was attenuated by S17092 incubation. S17092 treatment inhibited intracellular POP activity and decreased the AcSDKP level at the concentration of 0.026-26 mu M. After treatment with FFA for 24 h, oil red 0 staining revealed significant lipid accumulation in the cells in the model group compared with the controls; however, lipid accumulation was suppressed after the administration of S17092 (13 and 26 mu M). Accordingly, the triglyceride levels in the FFA-treated cells were approximately 5-fold greater than those of the controls and were decreased by approximately 25% and 45% after the administration of S17092 at 13 and 26 mu M, respectively. The mRNA levels of FASN, PPAR-gamma, and SREBP-1c were higher in the FFA-treated cells than in the normal controls, and all of these levels were significantly inhibited in the presence of S17092 at both 13 and 26 mu M. S17092 treatment did not affect LC3B II in the FFA-treated cells compared with FFA treatment alone.ConclusionThe expression of POP increases with hepatocyte steatosis, and POP inhibitors can significantly reduce intracellular lipid accumulation, which might be related to the inhibition of genes involved in lipid synthesis.

Inhibition of proliferation and regulation of heaptic fibrosis-related genes in HSC-T6 cells by prolyloligopeptidase inhibitor in vitro

Prolyl Oligopeptidase Attenuates Hepatic Stellate Cell Activation Through Induction of Smad7 and PPAR-γ.

The effects of ientivirus-mediated overexpression of prolyioligopeptidase in rat HSC-T6 cells

Oligomeric Proanthocyanidin Derived from Grape Seeds Inhibited NF-κB Signaling in Activated HSC: Involvement of JNK/ERK MAPK and PI3K/Akt Pathways

[Effects of Bone Morphogenic Proteins-7 on Production of Collagen from Hepatocytes and Hepatic Stellate Cells During Liver Fibrosis].

Combined Interventional Effects of PAP-M6P and RGDY on Activated Function of Hepatic Stellate Cells

[The Effect of Ligand of Peroxisome Proliferators-Activated Receptor Gamma 15D-Pgj2 on the Proliferation and Activation of Hepatic Stellate Cells].

Prolyl Oligopeptidase Inhibition Attenuates Steatosis in the L02 Human Liver Cell Line.

Ginsenoside PPD inhibit the activation of HSCs by directly targeting TGFβR1

Effects of peroxisome prolilerator-activated receptor γ agonists on transforming growth factor-β1 induced profibrotic activities in normal skin fibroblasts in vitro

PPAR Gamma Inhibits Growth of Rat Hepatic Stellate Cells and TGF Beta-Induced Connective Tissue Growth Factor Expression

ShRNA Targeted to Rat Smad3 Decreases the Profibrosis Role of TGFβ1 in HSC - T6 Cells

Effects of Peroxisome Proliferators-Activatied Receptor Gamma on the Biological Characteristics of Hepatic Stellate Cells

Effects of Peroxisome Proliferator-Activated Receptor Agonists on the Proliferation of Hepatic Stellate Cells

Regulation of Hepatic Stellate Cell Activation and Proliferation by Hedgehog Signal Pathway

Periostin Down-Regulation Attenuates The Pro-Fibrogenic Response Of Hepatic Stellate Cells Induced By Tgf-1

Effects of hydroxycamptothecin on TGFβ1, α-SMA and collagen I expression in rat hepatic satellite cells

Periostin down‐regulation attenuates the pro‐fibrogenic response of hepatic stellate cells induced by TGF‐β1

TGF-β1 Induces the Dual Regulation of Hepatic Progenitor Cells with Both Anti- and Proliver Fibrosis

Effect of RGD-M6P on Primary Hepatic Stellate Cells

Effects of phenylethanol glycosides from Cistanche tubulosa on proliferation of rat HSC induced by PDGF-BB and its mechanism